Aurora Cannabis Inc. (NASDAQ:ACB) Receives Average Rating of “Moderate Buy” from Analysts

Aurora Cannabis Inc. (NASDAQ:ACB) has received an average recommendation of “Moderate Buy” from the five ratings firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and two have given a strong buy rating to the company.

A number of research firms have recently commented on ACB. Zacks Research upgraded Aurora Cannabis from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Weiss Ratings restated a “sell (d-)” rating on shares of Aurora Cannabis in a report on Wednesday, October 8th.

Aurora Cannabis Price Performance

ACB opened at $4.60 on Friday. Aurora Cannabis has a 1 year low of $3.42 and a 1 year high of $6.91. The company’s 50 day simple moving average is $5.01 and its 200 day simple moving average is $4.98. The stock has a market capitalization of $260.82 million, a PE ratio of -6.67 and a beta of 1.71. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.63 and a current ratio of 3.41.

Aurora Cannabis (NASDAQ:ACB) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.06. The company had revenue of $64.88 million for the quarter, compared to analyst estimates of $86.45 million. Aurora Cannabis had a negative net margin of 15.96% and a negative return on equity of 0.58%. As a group, sell-side analysts expect that Aurora Cannabis will post 0.46 EPS for the current year.

Institutional Trading of Aurora Cannabis

Institutional investors have recently added to or reduced their stakes in the business. TD Asset Management Inc boosted its position in shares of Aurora Cannabis by 4.0% in the first quarter. TD Asset Management Inc now owns 60,949 shares of the company’s stock worth $267,000 after buying an additional 2,321 shares during the period. Mackenzie Financial Corp raised its stake in shares of Aurora Cannabis by 8.9% during the first quarter. Mackenzie Financial Corp now owns 27,783 shares of the company’s stock valued at $122,000 after purchasing an additional 2,280 shares during the period. Baader Bank Aktiengesellschaft lifted its position in shares of Aurora Cannabis by 95.1% during the first quarter. Baader Bank Aktiengesellschaft now owns 40,702 shares of the company’s stock worth $179,000 after purchasing an additional 19,844 shares in the last quarter. JW Asset Management LLC acquired a new position in shares of Aurora Cannabis during the first quarter worth $58,000. Finally, Northwest & Ethical Investments L.P. purchased a new position in shares of Aurora Cannabis in the first quarter valued at $452,000. 47.63% of the stock is owned by hedge funds and other institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.